VICL - Vical Inc - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Biological Products, (No Diagnostic Substances) - VICL (819050)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
P - Purchase
S - Sale
A - Grant
D - Sale to Iss
G - Gift
F - Tax
M - Option Ex
X - Option Ex
C - Cnv Deriv
W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title   Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10% Own
  Other
Group by
Sort by
Max Results
Page
clear
Real-time CSV, Options, Alerts
25 results - Yahoo - Google - Finviz - Stockcharts - Tradingview - Stocktwits - SEC
TCcnt1d1w1m6m
P4+4+0+2-45
S20+1-1-2+5

X

Filing Date

Trade Date

Ticker

Insider Name

Insider Title

Trade Type 

Share Price

Shares Traded

Shares Owned

Own chg

Value Traded

1d ret

1w ret

1m ret

6m ret

2017-11-10
VICLMerton Robert CDirP - Purchase$1.75+85,70095,451+879%+$149,975
2017-03-27
VICLRamos Anthony AlanVP, Chief Accounting OfficerS - Sale$2.17-4,2509,674-31%-$9,240+5-2+6
2017-03-15
VICLSmith Lawrence RussellVP, Vaccine ResearchS - Sale$2.31-87517,696-5%-$2,0210-3-4
2017-02-10
VICLSmith Lawrence RussellVP, Vaccine ResearchS - Sale$2.26-4,50018,571-20%-$10,160+3-4-1
2017-02-01
VICLSamant Vijay BPres, CEOS - Sale$2.16-3,75087,420-4%-$8,088-1+100
2017-01-11
VICLSmith Lawrence RussellVP, Vaccine ResearchS - Sale$2.48-5423,0710%-$1340-30
2017-01-10
VICLSamant Vijay BPres, CEOS - Sale$2.45-5,76391,170-6%-$14,1140-40
M
2016-12-21
VICLMerton Robert CDirS - Sale$2.24-4,0009,751-29%-$8,960+7+1-1
M
2016-12-19
VICLMerton Robert CDirS - Sale$2.21-4,32713,751-24%-$9,583+3+9+1
M
2016-12-12
VICLSamant Vijay BPres, CEOS - Sale$2.39-15,69996,933-14%-$37,588-1-7-4
2016-12-12
VICLDouglas R GordonDirS - Sale$2.39-10,07810,828-48%-$24,109-1-7-4
2016-12-05
VICLLyons Gary ADirS - Sale$2.30-7,0787,828-47%-$16,248+5+30
2016-10-11
VICLSmith Lawrence RussellVP, Vaccine ResearchS - Sale$3.05-5423,1250%-$165+1-3-16-29
2016-07-11
VICLSmith Lawrence RussellVP, Vaccine ResearchS - Sale$4.46-5423,1790%-$241-2-3-4-46
M
2016-06-13
VICLMerton Robert CDirP - Purchase$4.34+9,00018,078+99%+$39,098+7-20-45
2016-06-09
VICLSamant Vijay BPres, CEOP - Purchase$4.72+15,700112,632+16%+$74,154+3+7+7-41
2016-06-06
VICLDouglas R GordonDirP - Purchase$4.41+10,07820,906+93%+$44,444+7+2+1-47
2016-06-03
VICLLyons Gary ADirP - Purchase$4.39+7,07814,906+90%+$31,089-1-5+2-48
2016-03-15
VICLSmith Lawrence RussellVP, Vaccine ResearchS - Sale$0.41-8,750232,331-4%-$3,583-5-3-3-4
M
2016-03-01
VICLSamant Vijay BPres, CEOS - Sale$0.36-37,500969,326-4%-$13,556+5+14+3+4
2016-02-19
VICLRamos Anthony AlanVP, Chief Accounting OfficerS - Sale$0.33-7,500139,235-5%-$2,477+6+9+21+29
2016-01-25
VICLRamos Anthony AlanVP, Chief Accounting OfficerS - Sale$0.35-193146,7350%-$68-3-3-3+18
M
2016-01-11
VICLSamant Vijay BPres, CEOS - Sale$0.35-59,7371,006,826-6%-$20,7600-6-9+26
2016-01-11
VICLSmith Lawrence RussellVP, Vaccine ResearchS - Sale$0.36-974241,0810%-$3510-6-9+26
2016-01-07
VICLSamant Vijay BPres, CEOS - Sale$0.36-75,0001,066,563-7%-$27,090-8-6-11+22

Real-time CSV? Options? Alerts? Contact us!
AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top